PIF, ADQ weigh purchase of Egyptian drugmaker: report

26/11/2020 Argaam


Saudi Arabia’s Public Investment Fund (PIF) and UAE’s ADQ are weighing the joint purchase of Bausch Health Cos.’s Cairo-based drug unit, Bloomberg reported, citing people familiar with the matter.

 

Talks are ongoing and there’s no certainty the deliberations will lead to a transaction involving one or both of the funds, the people said.

 

In addition, the two funds have held talks to work closely on other transactions in areas such as food security, health care and industrials, the report noted.

Comments {{getCommentCount()}}

Be the first to comment

loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.